General and placental evidence remain distinguishable
Parallel subsections distinguish general vesicle mechanisms from placenta-specific findings, helping readers identify where evidence comes from other cell systems.
↳ Sections 2, 3, 4 and 6
During pregnancy, there is an intense crosstalk between mother and placenta. During the entire time of pregnancy, the maternal system deals with a huge amount of foreign (fetal) material released from the placenta, which can be referred to as placental exposome. Besides the release of hormones and growth factors, the placenta releases a variety of extracellular vesicles into maternal blood. These vesicles contain specific molecules including proteins, lipids, DNA as well as miRNA, all of which may have specific sites and modes of action on maternal cells. During normal pregnancy, the fine-tuning of factors and vesicles helps maintaining a viable and healthy pregnancy. However, in pregnancy pathologies such as preeclampsia, quantity and quality of the placenta-derived vesicles are altered leading to a deleterious effect on the maternal vascular system. This review focuses on the different types of placenta-derived extracellular vesicles in pregnancy with special emphasis on the interplay between these placental vesicles and the maternal system. Additionally, it displays new techniques and ideas for the analysis of the placental exposome with placental extracellular vesicles as a key aspect.
in pregnancy pathologies such as preeclampsia, quantity and quality of the placenta-derived vesicles are altered leading to a deleterious effect on the maternal vascular system.
cell and animal evidence does not establish the human maternal vascular effect at the certainty stated
Importantly, the syncytiotrophoblast represents the primary source of placenta-derived extracellular vesicles
cited marker-based studies support placental source attribution with limits on identifying vesicle origins
During normal pregnancy, placenta-derived extracellular vesicles are continuously released into the maternal circulation and thus prime the maternal immune system to the ongoing pregnancy
predominantly in vitro immune-cell evidence limits inference about immune priming across pregnancy
data from different studies as well as their reproducibility may not be comparable since extracellular vesicle diversity is high and isolation protocols differ leading to isolation of a variety of different extracellular vesicle subtypes.
documented mixed preparations support the qualified warning without a quantitative comparison of isolation protocols
In contrast to exosomes and microvesicles, the released multinucleated syncytial knots are trapped in the maternal lungs, the first capillary bed of the maternal blood stream behind the placenta
cited anatomical and histological studies support pulmonary trapping of the larger syncytial knots
Derived from the full evaluation — not a separate score.
Strengths
Parallel subsections distinguish general vesicle mechanisms from placenta-specific findings, helping readers identify where evidence comes from other cell systems.
↳ Sections 2, 3, 4 and 6
The review includes non-selective trophoblast miRNA sorting and the absence of endothelial gene-expression differences between healthy and preeclamptic vesicle exposures.
↳ Sections 3.2 and 5
Marker overlap and mixed vesicle preparations are connected to difficulties comparing studies and resolving cargo-versus-quantity effects.
↳ Sections 3.1, 6 and 7
Limitations
The synthesis largely covers mechanisms and open questions already addressed by the contemporary reviews it cites, without developing a distinct explanatory framework.
↳ Sections 1.1–7
No account explains how sources were identified or selected, leaving the coverage and assembly of the evidence base difficult to assess.
↳ Sections 1–7
The Abstract presents altered placental vesicles as causing vascular harm, while the body relies substantially on cell and animal models and includes a null endothelial-expression comparison.
↳ Abstract; Sections 4.2, 5 and 7
The review's parallel treatment of general vesicle biology and placenta-specific findings provides an accessible account of cargo, uptake and maternal responses. Its engagement with marker ambiguity, non-selective RNA sorting and the null endothelial-expression comparison prevents a uniformly affirmative mechanistic narrative. Nevertheless, source selection is undocumented and the exposome framing adds limited advance beyond the cited reviews. The Abstract states maternal vascular harm more definitively than the cell and animal evidence warrants, while the conclusion more appropriately preserves unresolved cargo-versus-quantity questions.
Nabu’s assessment, alongside the field’s view.
Are you an author of this paper?
The review brings placental vesicle biogenesis, cargo, trafficking and maternal responses into one organised account. Its exposome framing and concluding questions largely reiterate the agenda of closely related reviews rather than resolving an uncertainty.
The synthesis separates general cell biology from placental evidence and includes findings that complicate its mechanistic account. Source identification and selection are not described, and individual model studies receive limited critical appraisal.
Parallel general and placenta-specific subsections make the argument followable. The Abstract's declarative vascular-damage claim is stronger than the model-based evidence and uncertainties presented in the body.
The review engages methodological guidance, marker ambiguity, non-selective cargo sorting and a null endothelial-expression result. It connects isolation heterogeneity to unresolved questions, but only partly traces experimental model limitations into claims about maternal physiology.
Lower confidence on Reporting, Positioning — domain match limited.
Caveats4 of 4 checks
The reported numbers and statistics are consistent with the stated results.
Section 6.2 contains internal references to sections that do not exist. Competing interests are declared as none.
Conflict of interest: declared
158 references in manuscript 155 of 157 checkable references found in an index 1 are books, websites or datasets — counted, but not index-checkable 10 mistyped DOIs matched to the cited work by its details
References not verified automatically are resolved manually within 24 hours.
No retraction or expression of concern found in Crossref (includes Retraction Watch).
Sources: Crossref (incl. Retraction Watch) ✓
The strongest synthesized evidence for the primary claim comes from controlled in vitro endothelial studies and animal models showing preeclamptic EVs cause vascular dysfunction under experimental conditions.
The review's conclusions focus on open questions and the need for further research rather than naming any direct real-world application of its synthesized findings.
Researchers studying pregnancy biology could identify placental EV-based biomarkers that obstetricians use for early detection of preeclampsia in pregnant women.
Conflicting in vitro evidence on whether EV cargo alterations directly cause maternal vascular damage, combined with lack of standardized isolation protocols, limits clinical translation.
Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3
AI-generated, human-governed. Something look off? Contact us to request a review.
Keep reading
Other papers Nabu has evaluated blind, starting with the same field.
2026 · Biological sciences
up to 4.83 × 10¹¹/ml of HEK293 EVs were successfully cell-free engineered
TentativeFreya Lyssy, Jacqueline Guettler, Beatrice A Brugger, et al. · 2023 · Basic medicine
S1PR2 was found to be significantly down-regulated in BeWo cells when co-incubated with platelet-derived factors (P = 0.0055).
TentativeBandres-Meriz, Kunz, Havelund, et al. · 2023 · Clinical medicine
palmitoleoyl ethanolamine (POEA), an endocannabinoid-like lipid endogenously synthesized from palmitoleic acid, and N-acetyl-L-alanine were consistently associated with C-peptide in all the analyses
Supported